Release Date: 28/02/14 16:30 Summary: Half Yearly Report and Accounts Price Sensitive: No Download Document 511.05KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%